Free Trial
→ What President Trump’s Executive Order 14154 means for your money (From Stansberry Research) (Ad)tc pixel Free A Stock Alerts

Agilent Technologies (A) Financials

Agilent Technologies logo
$123.19 -3.54 (-2.79%)
Closing price 09/12/2025 03:59 PM Eastern
Extended Trading
$123.22 +0.03 (+0.03%)
As of 09/12/2025 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Agilent Technologies

Annual Income Statements for Agilent Technologies

This table shows Agilent Technologies' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 10/31/2014 10/31/2015 10/31/2016 10/31/2017 10/31/2018 10/31/2019 10/31/2020 10/31/2021 10/31/2022 10/31/2023 10/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 549 401 462 684 316 1,071 719 1,210 1,254 1,240 1,289
Consolidated Net Income / (Loss)		 549 401 462 684 316 1,071 719 1,210 1,254 1,240 1,289
Net Income / (Loss) Continuing Operations		 232 438 462 684 316 1,071 719 1,210 1,254 1,240 1,289
Total Pre-Tax Income 		229 480 544 803 946 919 842 1,360 1,504 1,339 1,521
Total Operating Income		 419 522 615 807 904 941 846 1,347 1,618 1,350 1,488
Total Gross Profit		 1,976 2,041 2,197 2,399 2,680 2,805 2,837 3,407 3,722 3,465 3,535
Total Revenue		 4,048 4,038 4,202 4,472 4,914 5,163 5,339 6,319 6,848 6,833 6,510
Operating Revenue		 4,048 4,038 4,202 4,472 4,914 5,163 5,339 6,319 6,848 6,833 6,510
Total Cost of Revenue		 2,072 1,997 2,005 2,073 2,234 2,358 2,502 2,912 3,126 3,368 2,975
Operating Cost of Revenue		 2,072 1,997 2,005 2,073 2,234 2,358 2,502 2,912 3,126 3,368 2,975
Total Operating Expenses		 1,557 1,519 1,582 1,592 1,776 1,864 1,991 2,060 2,104 2,115 2,047
Selling, General & Admin Expense		 1,199 1,189 1,253 1,251 1,389 1,460 1,496 1,619 1,637 1,634 1,568
Research & Development Expense		 358 330 329 341 387 404 495 441 467 481 479
Total Other Income / (Expense), net		 -190 -42 -71 -4.00 42 -22 -4.00 13 -114 -11 33
Interest Expense		 110 66 72 79 75 74 78 81 84 95 96
Interest & Investment Income		 9.00 7.00 11 22 38 36 8.00 2.00 9.00 51 80
Other Income / (Expense), net		 -89 17 -10 53 79 16 66 92 -39 33 49
Income Tax Expense		 -3.00 42 82 119 630 -152 123 150 250 99 232
Basic Earnings per Share		 $1.65 $1.20 $1.42 $2.12 $0.98 $3.41 $2.33 $3.98 $4.19 $4.22 $4.44
Weighted Average Basic Shares Outstanding		 333M 333M 326M 322M 321M 314M 309M 304M 299M 294M 290M
Diluted Earnings per Share		 $1.62 $1.20 $1.40 $2.10 $0.97 $3.37 $2.30 $3.94 $4.18 $4.19 $4.43
Weighted Average Diluted Shares Outstanding		 338M 335M 329M 326M 325M 318M 312M 307M 300M 296M 291M
Weighted Average Basic & Diluted Shares Outstanding		 335.32M 334.20M 325.40M 322.60M 322.40M 310.18M 306.85M 302.00M 296.07M 293.00M 285.60M
Cash Dividends to Common per Share		 $0.53 $0.40 $0.46 $0.53 $0.60 $0.66 $0.72 $0.78 $0.84 $0.90 $0.94

Quarterly Income Statements for Agilent Technologies

This table shows Agilent Technologies' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 1/31/2023 4/30/2023 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 352 302 111 475 348 308 282 351 318 215 336
Consolidated Net Income / (Loss)		 352 302 111 475 348 308 282 351 318 215 336
Net Income / (Loss) Continuing Operations		 352 302 111 475 348 308 282 351 318 215 336
Total Pre-Tax Income 		410 377 132 420 403 374 343 401 367 260 366
Total Operating Income		 426 383 133 408 384 363 333 408 376 300 360
Total Gross Profit		 968 924 658 915 908 856 855 916 899 866 888
Total Revenue		 1,756 1,717 1,672 1,688 1,658 1,573 1,578 1,701 1,681 1,668 1,738
Operating Revenue		 1,756 1,717 1,672 1,688 1,658 1,573 1,578 1,701 1,681 1,668 1,738
Total Cost of Revenue		 788 793 1,014 773 750 717 723 785 782 802 850
Operating Cost of Revenue		 788 793 1,014 773 750 717 723 785 782 802 850
Total Operating Expenses		 542 541 525 507 524 493 522 508 523 566 528
Selling, General & Admin Expense		 419 415 407 393 396 380 395 397 410 454 417
Research & Development Expense		 123 126 118 114 128 113 127 111 113 112 111
Total Other Income / (Expense), net		 -16 -6.00 -1.00 12 19 11 10 -7.00 -9.00 -40 6.00
Interest Expense		 25 24 24 22 22 20 22 32 28 29 28
Interest & Investment Income		 9.00 12 13 17 18 19 19 24 15 14 16
Other Income / (Expense), net		 0.00 6.00 10 17 23 12 13 1.00 4.00 -25 18
Income Tax Expense		 58 75 21 -55 55 66 61 50 49 45 30
Basic Earnings per Share		 $1.19 $1.02 $0.38 $1.63 $1.19 $1.05 $0.97 $1.23 $1.12 $0.75 $1.18
Weighted Average Basic Shares Outstanding		 296M 296M 294M 294M 293M 293M 290M 290M 285M 285M 284M
Diluted Earnings per Share		 $1.19 $1.02 $0.38 $1.60 $1.18 $1.05 $0.97 $1.23 $1.11 $0.75 $1.18
Weighted Average Diluted Shares Outstanding		 297M 297M 295M 296M 294M 293M 291M 291M 287M 285M 285M
Weighted Average Basic & Diluted Shares Outstanding		 295.70M 295.38M 292.59M 293.00M 293.06M 291.76M 287.33M 285.60M 285.10M 284.06M 283.50M

Annual Cash Flow Statements for Agilent Technologies

This table details how cash moves in and out of Agilent Technologies' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 10/31/2014 10/31/2015 10/31/2016 10/31/2017 10/31/2018 10/31/2019 10/31/2020 10/31/2021 10/31/2022 10/31/2023 10/31/2024
Net Change in Cash & Equivalents		 353 -1,025 286 391 -432 -866 59 43 -434 537 -261
Net Cash From Operating Activities		 731 512 793 889 1,087 1,021 921 1,485 1,312 1,772 1,751
Net Cash From Continuing Operating Activities		 731 512 793 889 1,087 1,021 921 1,485 1,312 1,772 1,751
Net Income / (Loss) Continuing Operations		 549 401 462 684 316 1,071 719 1,210 1,254 1,240 1,289
Consolidated Net Income / (Loss)		 549 401 462 684 316 1,071 719 1,210 1,254 1,240 1,289
Depreciation Expense		 384 253 246 212 210 238 308 321 317 271 257
Non-Cash Adjustments To Reconcile Net Income		 197 103 112 91 106 97 191 63 236 432 186
Changes in Operating Assets and Liabilities, net		 -377 -245 -27 -98 455 -385 -297 -109 -495 -171 19
Net Cash From Investing Activities		 -230 -400 -238 -304 -705 -1,590 -147 -749 -338 -310 -1,258
Net Cash From Continuing Investing Activities		 -230 -400 -238 -304 -705 -1,590 -147 -749 -338 -310 -1,258
Purchase of Property, Plant & Equipment		 -205 -98 -139 -176 -177 -155 -119 -188 -291 -298 -378
Acquisitions		 -38 -75 -261 -128 -516 -1,409 0.00 -547 -52 -51 -862
Purchase of Investments		 0.00 0.00 -80 -1.00 -11 -23 -20 -22 -13 - -5.00
Sale of Property, Plant & Equipment		 14 12 0.00 0.00 1.00 0.00 1.00 1.00 0.00 4.00 0.00
Divestitures		 2.00 3.00 0.00 2.00 - - - 0.00 0.00 50 0.00
Sale and/or Maturity of Investments		 1.00 0.00 1.00 - - 0.00 0.00 12 22 5.00 0.00
Other Investing Activities, net		 -4.00 -242 241 -1.00 -2.00 -3.00 -9.00 -5.00 -4.00 -20 -13
Net Cash From Financing Activities		 -117 -1,089 -268 -202 -797 -299 -717 -696 -1,372 -930 -752
Net Cash From Continuing Financing Activities		 -117 -1,089 -268 -202 -797 -299 -717 -696 -1,372 -930 -749
Repayment of Debt		 -1,096 0.00 -294 -290 -693 -706 -1,766 -424 -609 -35 -609
Repurchase of Common Equity		 -200 -267 -434 -194 -422 -723 -469 -788 -1,139 -575 -1,150
Payment of Dividends		 -176 -133 -150 -170 -191 -210 -222 -236 -250 -265 -274
Issuance of Debt		 1,186 0.00 554 400 483 1,302 1,717 773 635 0.00 1,237
Issuance of Common Equity		 188 58 62 66 56 54 60 55 58 67 77
Other Financing Activities, net		 -19 -747 -6.00 -14 -30 -16 -37 -76 -67 -122 -30
Effect of Exchange Rate Changes		 -31 -48 -1.00 8.00 -17 2.00 2.00 3.00 -36 - -2.00
Cash Interest Paid		 142 71 73 82 80 80 71 76 85 89 80
Cash Income Taxes Paid		 131 129 67 63 102 159 361 211 279 199 314

Quarterly Cash Flow Statements for Agilent Technologies

This table details how cash moves in and out of Agilent Technologies' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 1/31/2023 4/30/2023 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025
Net Change in Cash & Equivalents		 197 -75 154 261 157 -76 108 -450 138 19 48
Net Cash From Operating Activities		 296 398 562 516 485 333 452 481 431 221 362
Net Cash From Continuing Operating Activities		 296 398 562 516 485 333 452 481 431 221 362
Net Income / (Loss) Continuing Operations		 352 302 111 475 348 308 282 351 318 215 336
Consolidated Net Income / (Loss)		 352 302 111 475 348 308 282 351 318 215 336
Depreciation Expense		 67 71 71 62 62 63 63 69 72 73 72
Non-Cash Adjustments To Reconcile Net Income		 62 37 319 14 54 44 42 46 49 87 43
Changes in Operating Assets and Liabilities, net		 -185 -12 61 -35 21 -82 65 15 -8.00 -154 -89
Net Cash From Investing Activities		 -104 -77 -89 -40 -95 -109 -100 -954 -94 -114 -96
Net Cash From Continuing Investing Activities		 -104 -77 -89 -40 -95 -109 -100 -954 -94 -114 -96
Purchase of Property, Plant & Equipment		 -76 -57 -81 -84 -90 -103 -92 -93 -97 -114 -103
Net Cash From Financing Activities		 -17 -390 -322 -201 -240 -291 -246 25 -180 -116 -219
Net Cash From Continuing Financing Activities		 -17 -390 -322 -201 -240 -291 -246 28 -180 -116 -219
Repayment of Debt		 0.00 - - -35 -180 - - -429 -31 130 -88
Repurchase of Common Equity		 -75 -85 -335 -80 0.00 -230 -585 -335 -90 -175 -85
Payment of Dividends		 -67 -66 -66 -66 -69 -69 -68 -68 -71 -70 -71
Issuance of Common Equity		 35 - 30 2.00 34 9.00 33 1.00 30 1.00 29
Other Financing Activities, net		 -113 -1.00 -6.00 -2.00 -25 -1.00 -1.00 -3.00 -22 -2.00 -4.00
Other Net Changes in Cash		 - - - - 7.00 - - - -19 28 1.00
Cash Interest Paid		 15 29 16 29 14 26 10 30 3.00 48 4.00
Cash Income Taxes Paid		 17 111 15 56 24 200 60 30 19 229 56

Annual Balance Sheets for Agilent Technologies

This table presents Agilent Technologies' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 10/31/2014 10/31/2015 10/31/2016 10/31/2017 10/31/2018 10/31/2019 10/31/2020 10/31/2021 10/31/2022 10/31/2023 10/31/2024
Total Assets		 10,815 7,479 7,794 8,426 8,541 9,452 9,627 10,705 10,532 10,763 11,846
Total Current Assets		 5,509 3,686 3,635 4,169 3,848 3,189 3,415 3,799 3,778 4,186 3,959
Cash & Equivalents		 2,218 2,003 2,289 2,678 2,247 1,382 1,441 1,484 1,053 1,590 1,329
Accounts Receivable		 626 606 631 724 776 930 1,038 1,172 1,405 1,291 1,324
Inventories, net		 574 541 533 575 638 679 720 830 1,038 1,031 972
Other Current Assets		 263 294 182 192 187 198 216 222 282 274 334
Plant, Property, & Equipment, net		 631 604 639 757 822 850 845 945 1,100 1,270 1,778
Total Noncurrent Assets		 4,675 3,189 3,520 3,500 3,871 5,413 5,367 5,961 5,654 5,307 6,109
Long-Term Investments		 96 86 135 138 68 102 158 185 195 164 175
Goodwill		 2,507 2,366 2,517 2,607 2,973 3,593 3,602 3,975 3,952 3,960 4,477
Intangible Assets		 649 445 416 361 491 1,107 831 981 821 475 547
Other Noncurrent Operating Assets		 268 292 452 394 339 611 776 820 686 708 910
Total Liabilities & Shareholders' Equity		 10,815 7,479 7,794 8,426 8,541 9,452 9,627 10,705 10,532 10,763 11,846
Total Liabilities		 5,511 3,309 3,548 3,591 3,970 4,704 4,754 5,316 5,227 4,918 5,948
Total Current Liabilities		 1,692 976 945 1,263 1,171 2,080 1,467 1,708 1,861 1,603 1,895
Short-Term Debt		 - - 0.00 210 0.00 616 75 0.00 36 0.00 45
Accounts Payable		 302 279 257 305 340 354 354 446 580 418 540
Accrued Expenses		 - - - - - - - - - - 398
Current Deferred Revenue		 260 258 269 291 324 336 386 441 461 505 544
Current Employee Benefit Liabilities		 228 221 235 276 304 334 367 493 455 371 368
Total Noncurrent Liabilities		 3,819 2,333 2,603 2,328 2,799 2,624 3,287 3,608 3,366 3,315 4,053
Long-Term Debt		 1,663 1,655 1,904 1,801 1,799 1,791 2,284 2,729 2,733 2,735 3,345
Noncurrent Employee Benefit Liabilities		 209 264 360 234 239 360 389 220 97 103 130
Other Noncurrent Operating Liabilities		 513 414 339 293 761 473 614 659 536 477 578
Commitments & Contingencies		 - - - - - 0.00 - 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 5,304 4,170 4,246 4,835 4,571 4,748 4,873 5,389 5,305 5,845 5,898
Total Preferred & Common Equity		 5,301 4,167 4,243 4,831 4,567 4,748 4,873 5,389 5,305 5,845 5,898
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 5,301 4,167 4,243 4,831 4,567 4,748 4,873 5,389 5,305 5,845 5,898
Common Stock		 8,973 9,051 9,165 5,303 5,311 5,280 5,314 5,323 5,328 5,390 5,453
Retained Earnings		 6,469 5,581 6,089 -126 -336 -18 81 348 324 782 750
Accumulated Other Comprehensive Income / (Loss)		 -334 -391 -503 -346 -408 -514 -522 -282 -347 -327 -305

Quarterly Balance Sheets for Agilent Technologies

This table presents Agilent Technologies' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 1/31/2023 4/30/2023 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025
Total Assets		 10,919 10,792 10,675 10,763 10,948 10,856 10,996 11,846 11,914 12,158 12,226
Total Current Assets		 4,078 3,949 4,030 4,186 4,338 4,203 4,256 3,959 4,107 4,208 4,253
Cash & Equivalents		 1,250 1,175 1,329 1,590 1,748 1,671 1,779 1,329 1,467 1,486 1,535
Accounts Receivable		 1,459 1,401 1,339 1,291 1,295 1,249 1,227 1,324 1,328 1,366 1,382
Inventories, net		 1,111 1,103 1,072 1,031 1,033 1,000 978 972 997 991 1,014
Other Current Assets		 258 270 290 274 262 283 272 334 315 365 322
Plant, Property, & Equipment, net		 1,147 1,184 1,211 1,270 1,314 1,371 1,446 1,778 1,816 1,912 1,966
Total Noncurrent Assets		 5,694 5,659 5,434 5,307 5,296 5,282 5,294 6,109 5,991 6,038 6,007
Long-Term Investments		 188 186 190 164 170 177 186 175 173 135 133
Goodwill		 3,983 3,980 3,984 3,960 3,967 3,963 3,965 4,477 4,429 4,474 4,475
Intangible Assets		 810 798 502 475 443 417 392 547 514 495 469
Other Noncurrent Operating Assets		 713 695 758 708 716 725 751 910 875 934 930
Total Liabilities & Shareholders' Equity		 10,919 10,792 10,675 10,763 10,948 10,856 10,996 11,846 11,914 12,158 12,226
Total Liabilities		 5,310 5,011 5,117 4,918 4,760 4,642 5,093 5,948 5,887 6,022 5,856
Total Current Liabilities		 1,936 1,666 1,760 1,603 1,617 1,958 2,389 1,895 1,869 2,012 1,892
Short-Term Debt		 238 0.00 55 0.00 - 420 795 45 16 146 59
Accounts Payable		 540 479 452 418 488 461 497 540 547 517 530
Accrued Expenses		 341 309 410 - 335 218 264 398 436 374 337
Current Deferred Revenue		 521 519 512 505 522 533 524 544 612 628 620
Current Employee Benefit Liabilities		 296 359 331 371 272 326 309 368 258 347 346
Total Noncurrent Liabilities		 3,374 3,345 3,357 3,315 3,143 2,684 2,704 4,053 4,018 4,010 3,964
Long-Term Debt		 2,733 2,733 2,734 2,735 2,555 2,136 2,137 3,345 3,347 3,349 3,350
Noncurrent Employee Benefit Liabilities		 99 97 92 103 102 99 96 130 120 126 119
Other Noncurrent Operating Liabilities		 542 515 531 477 486 449 471 578 551 535 495
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 5,609 5,781 5,558 5,845 6,188 6,214 5,903 5,898 6,027 6,136 6,370
Total Preferred & Common Equity		 5,609 5,781 5,558 5,845 6,188 6,214 5,903 5,898 6,027 6,136 6,370
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 5,609 5,781 5,558 5,845 6,188 6,214 5,903 5,898 6,027 6,136 6,370
Common Stock		 5,348 5,363 5,385 5,390 5,443 5,461 5,461 5,453 5,492 5,504 5,551
Retained Earnings		 541 700 444 782 1,061 1,090 773 750 916 912 1,102
Accumulated Other Comprehensive Income / (Loss)		 -280 -282 -271 -327 -316 -337 -331 -305 -381 -280 -283

Annual Metrics And Ratios for Agilent Technologies

This table displays calculated financial ratios and metrics derived from Agilent Technologies' official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 10/31/2014 10/31/2015 10/31/2016 10/31/2017 10/31/2018 10/31/2019 10/31/2020 10/31/2021 10/31/2022 10/31/2023 10/31/2024
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 3.95% -0.25% 4.06% 6.43% 9.88% 5.07% 3.41% 18.36% 8.37% -0.22% -4.73%
EBITDA Growth		 -9.54% 14.45% 7.45% 25.97% 11.29% 0.17% 2.09% 44.26% 7.73% -12.76% 8.46%
EBIT Growth		 -16.03% 63.33% 12.24% 42.15% 14.30% -2.65% -4.70% 57.79% 9.73% -12.41% 11.14%
NOPAT Growth		 43.21% 12.21% 9.65% 31.61% -56.07% 263.16% -34.12% 65.89% 12.57% -7.33% 0.87%
Net Income Growth		 -25.20% -26.96% 15.21% 48.05% -53.80% 238.92% -32.87% 68.29% 3.64% -1.12% 3.95%
EPS Growth		 -25.20% -25.93% 16.67% 50.00% -53.81% 247.42% -31.75% 71.30% 6.09% 0.24% 5.73%
Operating Cash Flow Growth		 -36.55% -29.96% 54.88% 12.11% 22.27% -6.07% -9.79% 61.24% -11.65% 35.06% -1.19%
Free Cash Flow Firm Growth		 793.67% -62.10% -59.07% 32.07% -27.76% -287.52% 246.41% -37.74% 86.10% 41.90% -75.76%
Invested Capital Growth		 -27.97% -6.25% 6.64% 8.16% 0.62% 39.85% -0.67% 12.87% 7.36% 0.00% 14.03%
Revenue Q/Q Growth		 120.60% -0.20% 1.84% 1.78% 2.18% 1.43% 2.22% 2.88% 2.84% -2.30% 0.20%
EBITDA Q/Q Growth		 62.82% 18.92% 0.59% 6.77% 1.45% 1.19% 4.72% 11.04% -0.32% -3.44% -0.50%
EBIT Q/Q Growth		 602.13% 41.84% 1.51% 9.14% 1.34% -0.62% 6.42% 13.13% 0.32% -3.35% -1.03%
NOPAT Q/Q Growth		 778.86% 12.46% 0.02% -0.05% 9.47% 1.97% 3.63% 15.64% -1.38% 7.30% -7.64%
Net Income Q/Q Growth		 -21.79% 21.88% -2.94% 8.06% 6.04% -0.09% 4.05% 22.22% -5.57% 9.44% -8.78%
EPS Q/Q Growth		 -21.79% 21.21% -4.11% 6.60% 6.59% 0.90% 3.60% 23.13% -4.78% 9.40% -7.71%
Operating Cash Flow Q/Q Growth		 -20.89% 12.53% -0.88% 6.47% 8.37% -5.38% 7.34% 4.50% 0.54% 3.99% -1.96%
Free Cash Flow Firm Q/Q Growth		 967.64% -66.64% 20.37% -33.29% 171.96% -192.67% 281.10% -28.53% 9.05% 16.93% -77.10%
Invested Capital Q/Q Growth		 -29.69% -2.89% -3.94% 0.95% -2.66% 21.15% -2.85% 3.01% 1.40% -0.03% 13.30%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 48.81% 50.54% 52.28% 53.64% 54.54% 54.33% 53.14% 53.92% 54.35% 50.71% 54.30%
EBITDA Margin		 17.09% 19.61% 20.25% 23.97% 24.28% 23.15% 22.85% 27.85% 27.69% 24.21% 27.56%
Operating Margin		 10.35% 12.93% 14.64% 18.05% 18.40% 18.23% 15.85% 21.32% 23.63% 19.76% 22.86%
EBIT Margin		 8.15% 13.35% 14.40% 19.23% 20.00% 18.54% 17.08% 22.77% 23.06% 20.24% 23.61%
Profit (Net Income) Margin		 13.56% 9.93% 10.99% 15.30% 6.43% 20.74% 13.47% 19.15% 18.31% 18.15% 19.80%
Tax Burden Percent		 239.74% 83.54% 84.93% 85.18% 33.40% 116.54% 85.39% 88.97% 83.38% 92.61% 84.75%
Interest Burden Percent		 69.39% 89.05% 89.92% 93.37% 96.24% 96.03% 92.32% 94.51% 95.25% 96.82% 98.96%
Effective Tax Rate		 -1.31% 8.75% 15.07% 14.82% 66.60% -16.54% 14.61% 11.03% 16.62% 7.39% 15.25%
Return on Invested Capital (ROIC)		 9.54% 13.19% 14.47% 17.73% 7.47% 22.55% 12.78% 19.99% 20.47% 18.32% 17.26%
ROIC Less NNEP Spread (ROIC-NNEP)		 -5.18% 19.88% 24.55% 18.24% 5.35% 9.95% 12.38% 21.33% 12.83% 17.50% 19.21%
Return on Net Nonoperating Assets (RNNOA)		 0.83% -4.73% -3.49% -2.66% -0.75% 0.43% 2.16% 3.59% 2.99% 3.93% 4.69%
Return on Equity (ROE)		 10.37% 8.47% 10.98% 15.06% 6.72% 22.99% 14.95% 23.58% 23.45% 22.24% 21.95%
Cash Return on Invested Capital (CROIC)		 42.05% 19.65% 8.04% 9.89% 6.85% -10.68% 13.45% 7.90% 13.37% 18.32% 4.15%
Operating Return on Assets (OROA)		 3.07% 5.89% 7.92% 10.60% 11.59% 10.64% 9.56% 14.16% 14.87% 12.99% 13.60%
Return on Assets (ROA)		 5.11% 4.38% 6.05% 8.43% 3.72% 11.90% 7.54% 11.90% 11.81% 11.65% 11.40%
Return on Common Equity (ROCE)		 10.36% 8.46% 10.97% 15.05% 6.71% 22.98% 14.95% 23.58% 23.45% 22.24% 21.95%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 9.62% 10.89% 14.16% 6.92% 22.56% 14.75% 22.45% 23.64% 21.21% 21.85%
Net Operating Profit after Tax (NOPAT)		 424 476 522 687 302 1,097 722 1,198 1,349 1,250 1,261
NOPAT Margin		 10.49% 11.80% 12.43% 15.37% 6.15% 21.24% 13.53% 18.97% 19.70% 18.30% 19.37%
Net Nonoperating Expense Percent (NNEP)		 14.72% -6.69% -10.08% -0.51% 2.12% 12.60% 0.41% -1.34% 7.63% 0.81% -1.95%
Return On Investment Capital (ROIC_SIMPLE)		 6.09% 8.18% 8.49% 10.04% 4.74% 15.33% 9.99% 14.76% 16.71% 14.57% 13.58%
Cost of Revenue to Revenue		 51.19% 49.46% 47.72% 46.36% 45.46% 45.67% 46.86% 46.08% 45.65% 49.29% 45.70%
SG&A Expenses to Revenue		 29.62% 29.45% 29.82% 27.97% 28.27% 28.28% 28.02% 25.62% 23.90% 23.91% 24.09%
R&D to Revenue		 8.84% 8.17% 7.83% 7.63% 7.88% 7.82% 9.27% 6.98% 6.82% 7.04% 7.36%
Operating Expenses to Revenue		 38.46% 37.62% 37.65% 35.60% 36.14% 36.10% 37.29% 32.60% 30.72% 30.95% 31.44%
Earnings before Interest and Taxes (EBIT)		 330 539 605 860 983 957 912 1,439 1,579 1,383 1,537
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 692 792 851 1,072 1,193 1,195 1,220 1,760 1,896 1,654 1,794
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 3.18 2.79 3.13 4.29 4.32 4.76 6.28 8.65 7.60 5.13 6.34
Price to Tangible Book Value (P/TBV)		 7.86 8.57 10.12 11.13 17.90 470.97 69.58 107.71 75.79 21.27 42.76
Price to Revenue (P/Rev)		 4.17 2.88 3.16 4.64 4.02 4.38 5.73 7.38 5.89 4.39 5.74
Price to Earnings (P/E)		 30.72 28.97 28.70 30.32 62.47 21.11 42.58 38.54 32.15 24.18 28.99
Dividend Yield		 1.04% 1.14% 1.13% 0.82% 0.96% 0.90% 0.73% 0.50% 0.62% 0.88% 0.73%
Earnings Yield		 3.26% 3.45% 3.48% 3.30% 1.60% 4.74% 2.35% 2.59% 3.11% 4.14% 3.45%
Enterprise Value to Invested Capital (EV/IC)		 4.35 3.13 3.42 4.95 4.74 4.15 5.57 7.49 6.13 4.54 5.04
Enterprise Value to Revenue (EV/Rev)		 4.01 2.71 3.03 4.46 3.91 4.56 5.88 7.53 6.11 4.53 6.03
Enterprise Value to EBITDA (EV/EBITDA)		 23.44 13.82 14.97 18.60 16.12 19.69 25.72 27.05 22.07 18.72 21.88
Enterprise Value to EBIT (EV/EBIT)		 49.15 20.30 21.06 23.19 19.56 24.59 34.40 33.08 26.50 22.39 25.54
Enterprise Value to NOPAT (EV/NOPAT)		 38.21 22.97 24.40 29.01 63.68 21.46 43.43 39.72 31.02 24.77 31.13
Enterprise Value to Operating Cash Flow (EV/OCF)		 22.19 21.37 16.07 22.43 17.69 23.05 34.07 32.06 31.89 17.48 22.42
Enterprise Value to Free Cash Flow (EV/FCFF)		 8.67 15.43 43.90 52.01 69.43 0.00 41.26 100.55 47.49 24.77 129.55
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.31 0.40 0.45 0.42 0.39 0.51 0.48 0.51 0.52 0.47 0.57
Long-Term Debt to Equity		 0.31 0.40 0.45 0.37 0.39 0.38 0.47 0.51 0.52 0.47 0.57
Financial Leverage		 -0.16 -0.24 -0.14 -0.15 -0.14 0.04 0.17 0.17 0.23 0.22 0.24
Leverage Ratio		 2.03 1.93 1.81 1.79 1.80 1.93 1.98 1.98 1.99 1.91 1.93
Compound Leverage Factor		 1.41 1.72 1.63 1.67 1.74 1.85 1.83 1.87 1.89 1.85 1.91
Debt to Total Capital		 23.87% 28.41% 30.96% 29.37% 28.24% 33.64% 32.62% 33.62% 34.30% 31.88% 36.50%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 3.07% 0.00% 8.61% 1.04% 0.00% 0.45% 0.00% 0.48%
Long-Term Debt to Total Capital		 23.87% 28.41% 30.96% 26.31% 28.24% 25.03% 31.58% 33.62% 33.85% 31.88% 36.01%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.04% 0.05% 0.05% 0.06% 0.06% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 76.09% 71.54% 68.99% 70.57% 71.70% 66.36% 67.38% 66.38% 65.70% 68.12% 63.50%
Debt to EBITDA		 2.40 2.09 2.24 1.88 1.51 2.01 1.93 1.55 1.46 1.65 1.89
Net Debt to EBITDA		 -0.94 -0.85 -0.61 -0.75 -0.43 0.77 0.62 0.55 0.80 0.59 1.05
Long-Term Debt to EBITDA		 2.40 2.09 2.24 1.68 1.51 1.50 1.87 1.55 1.44 1.65 1.86
Debt to NOPAT		 3.92 3.47 3.65 2.93 5.96 2.19 3.27 2.28 2.05 2.19 2.69
Net Debt to NOPAT		 -1.53 -1.42 -1.00 -1.17 -1.71 0.84 1.05 0.81 1.13 0.78 1.50
Long-Term Debt to NOPAT		 3.92 3.47 3.65 2.62 5.96 1.63 3.16 2.28 2.03 2.19 2.65
Altman Z-Score		 3.57 4.36 4.55 4.73 4.26 3.90 4.99 6.58 6.03 5.11 5.05
Noncontrolling Interest Sharing Ratio		 0.06% 0.06% 0.07% 0.08% 0.09% 0.04% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 3.26 3.78 3.85 3.30 3.29 1.53 2.33 2.22 2.03 2.61 2.09
Quick Ratio		 1.68 2.67 3.09 2.69 2.58 1.11 1.69 1.61 1.32 1.80 1.40
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 1,871 709 290 383 277 -519 760 473 881 1,250 303
Operating Cash Flow to CapEx		 382.72% 595.35% 570.50% 505.11% 617.61% 658.71% 780.51% 794.12% 450.86% 602.72% 463.23%
Free Cash Flow to Firm to Interest Expense		 17.01 10.75 4.03 4.85 3.69 -7.02 9.75 5.84 10.49 13.16 3.16
Operating Cash Flow to Interest Expense		 6.65 7.76 11.01 11.25 14.49 13.80 11.81 18.33 15.62 18.65 18.24
Operating Cash Flow Less CapEx to Interest Expense		 4.91 6.45 9.08 9.03 12.15 11.70 10.29 16.02 12.15 15.56 14.30
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.38 0.44 0.55 0.55 0.58 0.57 0.56 0.62 0.64 0.64 0.58
Accounts Receivable Turnover		 5.31 6.56 6.79 6.60 6.55 6.05 5.43 5.72 5.31 5.07 4.98
Inventory Turnover		 2.53 3.58 3.73 3.74 3.68 3.58 3.58 3.76 3.35 3.26 2.97
Fixed Asset Turnover		 4.59 6.54 6.76 6.41 6.22 6.18 6.30 7.06 6.70 5.77 4.27
Accounts Payable Turnover		 5.65 6.87 7.48 7.38 6.93 6.80 7.07 7.28 6.09 6.75 6.21
Days Sales Outstanding (DSO)		 68.75 55.68 53.73 55.30 55.71 60.30 67.27 63.83 68.68 72.01 73.31
Days Inventory Outstanding (DIO)		 144.45 101.90 97.76 97.54 99.09 101.93 102.05 97.14 109.06 112.11 122.87
Days Payable Outstanding (DPO)		 64.65 53.10 48.79 49.48 52.69 53.71 51.64 50.14 59.90 54.08 58.77
Cash Conversion Cycle (CCC)		 148.55 104.48 102.70 103.36 102.11 108.52 117.67 110.83 117.83 130.04 137.41
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 3,727 3,494 3,726 4,030 4,055 5,671 5,633 6,358 6,826 6,826 7,784
Invested Capital Turnover		 0.91 1.12 1.16 1.15 1.22 1.06 0.94 1.05 1.04 1.00 0.89
Increase / (Decrease) in Invested Capital		 -1,447 -233 232 304 25 1,616 -38 725 468 0.00 958
Enterprise Value (EV)		 16,218 10,942 12,743 19,939 19,229 23,530 31,374 47,606 41,842 30,967 39,259
Market Capitalization		 16,866 11,615 13,260 20,740 19,741 22,607 30,614 46,637 40,321 29,986 37,373
Book Value per Share		 $15.89 $12.57 $13.08 $15.01 $14.33 $15.34 $15.81 $17.80 $17.92 $19.98 $20.53
Tangible Book Value per Share		 $6.43 $4.09 $4.04 $5.79 $3.46 $0.16 $1.43 $1.43 $1.80 $4.82 $3.04
Total Capital		 6,967 5,825 6,150 6,846 6,370 7,155 7,232 8,118 8,074 8,580 9,288
Total Debt		 1,663 1,655 1,904 2,011 1,799 2,407 2,359 2,729 2,769 2,735 3,390
Total Long-Term Debt		 1,663 1,655 1,904 1,801 1,799 1,791 2,284 2,729 2,733 2,735 3,345
Net Debt		 -651 -676 -520 -805 -516 923 760 969 1,521 981 1,886
Capital Expenditures (CapEx)		 191 86 139 176 176 155 118 187 291 294 378
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 1,599 465 401 438 430 343 582 516 900 993 780
Debt-free Net Working Capital (DFNWC)		 3,817 2,710 2,690 3,116 2,677 1,725 2,023 2,091 1,953 2,583 2,109
Net Working Capital (NWC)		 3,817 2,710 2,690 2,906 2,677 1,109 1,948 2,091 1,917 2,583 2,064
Net Nonoperating Expense (NNE)		 -125 75 60 3.41 -14 26 3.42 -12 95 10 -28
Net Nonoperating Obligations (NNO)		 -1,577 -676 -520 -805 -516 923 760 969 1,521 981 1,886
Total Depreciation and Amortization (D&A)		 362 253 246 212 210 238 308 321 317 271 257
Debt-free, Cash-free Net Working Capital to Revenue		 39.50% 11.52% 9.54% 9.79% 8.75% 6.64% 10.90% 8.17% 13.14% 14.53% 11.98%
Debt-free Net Working Capital to Revenue		 94.29% 67.11% 64.02% 69.68% 54.48% 33.41% 37.89% 33.09% 28.52% 37.80% 32.40%
Net Working Capital to Revenue		 94.29% 67.11% 64.02% 64.98% 54.48% 21.48% 36.49% 33.09% 27.99% 37.80% 31.71%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.51 $1.20 $1.42 $2.12 $0.98 $3.41 $2.33 $3.98 $4.19 $4.22 $4.44
Adjusted Weighted Average Basic Shares Outstanding		 333M 333M 326M 322M 321M 314M 309M 304M 299M 294M 290M
Adjusted Diluted Earnings per Share		 $1.49 $1.20 $1.40 $2.10 $0.97 $3.37 $2.30 $3.94 $4.18 $4.19 $4.43
Adjusted Weighted Average Diluted Shares Outstanding		 338M 335M 329M 326M 325M 318M 312M 307M 300M 296M 291M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $3.41 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 335.32M 332.17M 321.75M 323.02M 318.53M 310.18M 306.85M 302.00M 296.07M 293.00M 285.60M
Normalized Net Operating Profit after Tax (NOPAT)		 293 476 522 687 633 659 722 1,198 1,349 1,250 1,261
Normalized NOPAT Margin		 7.25% 11.80% 12.43% 15.37% 12.88% 12.76% 13.53% 18.97% 19.70% 18.30% 19.37%
Pre Tax Income Margin		 5.66% 11.89% 12.95% 17.96% 19.25% 17.80% 15.77% 21.52% 21.96% 19.60% 23.36%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 3.00 8.17 8.40 10.89 13.11 12.93 11.69 17.77 18.80 14.56 16.01
NOPAT to Interest Expense		 3.86 7.22 7.25 8.70 4.03 14.82 9.26 14.80 16.06 13.16 13.14
EBIT Less CapEx to Interest Expense		 1.26 6.86 6.47 8.66 10.76 10.84 10.18 15.46 15.33 11.46 12.07
NOPAT Less CapEx to Interest Expense		 2.12 5.91 5.32 6.47 1.68 12.72 7.75 12.49 12.60 10.07 9.20
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 32.06% 33.17% 32.47% 24.85% 60.44% 19.61% 30.88% 19.50% 19.94% 21.37% 21.26%
Augmented Payout Ratio		 68.49% 99.75% 126.41% 53.22% 193.99% 87.11% 96.11% 84.63% 110.77% 67.74% 110.47%

Quarterly Metrics And Ratios for Agilent Technologies

This table displays calculated financial ratios and metrics derived from Agilent Technologies' official financial filings.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 1/31/2023 4/30/2023 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 4.90% 6.85% -2.68% -8.71% -5.58% -8.39% -5.62% 0.77% 1.39% 6.04% 10.14%
EBITDA Growth		 17.10% 5.75% -56.68% -10.81% -4.87% -4.78% 91.12% -1.85% -3.62% -20.55% 10.02%
EBIT Growth		 25.66% 10.20% -65.46% -10.15% -4.46% -3.60% 141.96% -3.76% -6.63% -26.67% 9.25%
NOPAT Growth		 9.64% 3.58% -67.16% 21.13% -9.34% -2.56% 144.79% -22.60% -1.75% -17.01% 20.72%
Net Income Growth		 24.38% 10.22% -66.26% 29.08% -1.14% 1.99% 154.05% -26.11% -8.62% -30.19% 19.15%
EPS Growth		 27.96% 12.09% -65.45% 29.03% -0.84% 2.94% 155.26% -23.13% -5.93% -28.57% 21.65%
Operating Cash Flow Growth		 16.08% 40.64% 72.39% 15.18% 63.85% -16.33% -19.57% -6.78% -11.13% -33.63% -19.91%
Free Cash Flow Firm Growth		 38.52% -35.30% 107.22% 630.02% 368.83% 345.12% 1,363.16% -230.22% -192.38% -258.49% -492.84%
Invested Capital Growth		 9.29% 7.89% 1.43% 0.00% -4.44% -3.23% 0.62% 14.03% 13.55% 15.72% 18.06%
Revenue Q/Q Growth		 -5.03% -2.22% -2.62% 0.96% -1.78% -5.13% 0.32% 7.79% -1.18% -0.77% 4.20%
EBITDA Q/Q Growth		 -9.71% -6.69% -53.48% 127.57% -3.70% -6.61% -6.62% 16.87% -5.44% -23.01% 29.31%
EBIT Q/Q Growth		 -9.94% -8.69% -63.24% 197.20% -4.24% -7.86% -7.73% 18.21% -7.09% -27.63% 37.45%
NOPAT Q/Q Growth		 -3.99% -16.11% -63.55% 312.58% -28.14% -9.85% -8.42% 30.44% -8.77% -23.86% 33.22%
Net Income Q/Q Growth		 -4.35% -14.20% -63.25% 327.93% -26.74% -11.49% -8.44% 24.47% -9.40% -32.39% 56.28%
EPS Q/Q Growth		 -4.03% -14.29% -62.75% 321.05% -26.25% -11.02% -7.62% 26.80% -9.76% -32.43% 57.33%
Operating Cash Flow Q/Q Growth		 -33.93% 34.46% 41.21% -8.19% -6.01% -31.34% 35.74% 6.42% -10.40% -48.72% 63.80%
Free Cash Flow Firm Q/Q Growth		 -177.13% 10.39% 107.33% 2,812.89% 40.56% -18.29% -56.26% -359.24% 0.28% -40.17% -8.40%
Invested Capital Q/Q Growth		 4.63% 0.15% -4.54% -0.03% -0.01% 1.42% -0.75% 13.30% -0.44% 3.35% 1.26%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 55.13% 53.81% 39.35% 54.21% 54.76% 54.42% 54.18% 53.85% 53.48% 51.92% 51.09%
EBITDA Margin		 28.08% 26.79% 12.80% 28.85% 28.29% 27.84% 25.92% 28.10% 26.89% 20.86% 25.89%
Operating Margin		 24.26% 22.31% 7.95% 24.17% 23.16% 23.08% 21.10% 23.99% 22.37% 17.99% 20.71%
EBIT Margin		 24.26% 22.66% 8.55% 25.18% 24.55% 23.84% 21.93% 24.04% 22.61% 16.49% 21.75%
Profit (Net Income) Margin		 20.05% 17.59% 6.64% 28.14% 20.99% 19.58% 17.87% 20.63% 18.92% 12.89% 19.33%
Tax Burden Percent		 85.85% 80.11% 84.09% 113.10% 86.35% 82.35% 82.22% 87.53% 86.65% 82.69% 91.80%
Interest Burden Percent		 96.24% 96.92% 92.31% 98.82% 99.02% 99.73% 99.13% 98.04% 96.58% 94.55% 96.83%
Effective Tax Rate		 14.15% 19.89% 15.91% -13.10% 13.65% 17.65% 17.78% 12.47% 13.35% 17.31% 8.20%
Return on Invested Capital (ROIC)		 21.11% 18.25% 6.90% 27.36% 19.29% 17.80% 16.46% 18.71% 17.37% 13.20% 17.23%
ROIC Less NNEP Spread (ROIC-NNEP)		 20.16% 17.92% 6.84% 28.45% 20.80% 18.67% 17.19% 18.28% 16.71% 10.64% 17.64%
Return on Net Nonoperating Assets (RNNOA)		 5.46% 4.73% 1.87% 6.38% 3.83% 3.24% 3.36% 4.46% 3.23% 2.22% 3.89%
Return on Equity (ROE)		 26.57% 22.99% 8.77% 33.75% 23.11% 21.04% 19.81% 23.17% 20.60% 15.43% 21.12%
Cash Return on Invested Capital (CROIC)		 11.36% 12.64% 15.77% 18.32% 21.92% 20.39% 19.32% 4.15% 4.53% 1.57% 0.30%
Operating Return on Assets (OROA)		 15.83% 15.01% 5.65% 16.16% 15.12% 14.52% 13.15% 13.85% 12.92% 9.50% 12.71%
Return on Assets (ROA)		 13.08% 11.66% 4.39% 18.06% 12.93% 11.92% 10.72% 11.88% 10.81% 7.42% 11.30%
Return on Common Equity (ROCE)		 26.57% 22.99% 8.77% 33.75% 23.11% 21.04% 19.81% 23.17% 20.60% 15.43% 21.12%
Return on Equity Simple (ROE_SIMPLE)		 23.59% 23.37% 20.39% 0.00% 19.97% 19.99% 23.94% 0.00% 20.89% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 366 307 112 461 332 299 274 357 326 248 330
NOPAT Margin		 20.83% 17.87% 6.69% 27.34% 20.00% 19.00% 17.35% 21.00% 19.38% 14.87% 19.02%
Net Nonoperating Expense Percent (NNEP)		 0.94% 0.33% 0.06% -1.08% -1.51% -0.87% -0.74% 0.43% 0.66% 2.56% -0.41%
Return On Investment Capital (ROIC_SIMPLE)		 4.26% 3.60% 1.34% 5.38% 3.79% 3.41% 3.10% 3.85% 3.47% 2.58% 3.38%
Cost of Revenue to Revenue		 44.87% 46.19% 60.65% 45.79% 45.24% 45.58% 45.82% 46.15% 46.52% 48.08% 48.91%
SG&A Expenses to Revenue		 23.86% 24.17% 24.34% 23.28% 23.88% 24.16% 25.03% 23.34% 24.39% 27.22% 23.99%
R&D to Revenue		 7.00% 7.34% 7.06% 6.75% 7.72% 7.18% 8.05% 6.53% 6.72% 6.71% 6.39%
Operating Expenses to Revenue		 30.87% 31.51% 31.40% 30.04% 31.60% 31.34% 33.08% 29.86% 31.11% 33.93% 30.38%
Earnings before Interest and Taxes (EBIT)		 426 389 143 425 407 375 346 409 380 275 378
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 493 460 214 487 469 438 409 478 452 348 450
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 7.91 6.84 6.40 5.13 6.11 6.43 6.96 6.34 7.16 4.99 5.12
Price to Tangible Book Value (P/TBV)		 54.40 39.43 33.20 21.27 21.26 21.78 26.59 42.76 39.84 26.23 22.87
Price to Revenue (P/Rev)		 6.41 5.62 5.09 4.39 5.61 6.06 6.33 5.74 6.61 4.62 4.80
Price to Earnings (P/E)		 33.56 29.27 31.41 24.18 30.59 32.16 29.10 28.99 34.30 26.25 26.73
Dividend Yield		 0.57% 0.65% 0.73% 0.88% 0.71% 0.68% 0.66% 0.73% 0.63% 0.90% 0.85%
Earnings Yield		 2.98% 3.42% 3.18% 4.14% 3.27% 3.11% 3.44% 3.45% 2.92% 3.81% 3.74%
Enterprise Value to Invested Capital (EV/IC)		 6.43 5.72 5.40 4.54 5.63 5.87 6.13 5.04 5.79 4.06 4.24
Enterprise Value to Revenue (EV/Rev)		 6.63 5.81 5.27 4.53 5.71 6.17 6.48 6.03 6.87 4.90 5.06
Enterprise Value to EBITDA (EV/EBITDA)		 23.34 20.53 21.52 18.72 23.58 25.28 23.34 21.88 25.27 19.26 19.88
Enterprise Value to EBIT (EV/EBIT)		 27.57 24.04 25.76 22.39 28.18 30.12 27.10 25.54 29.74 23.04 23.82
Enterprise Value to NOPAT (EV/NOPAT)		 33.19 29.36 31.63 24.77 31.67 33.78 30.82 31.13 35.79 26.96 27.18
Enterprise Value to Operating Cash Flow (EV/OCF)		 33.94 27.87 21.63 17.48 19.60 21.44 23.56 22.42 26.46 20.50 22.98
Enterprise Value to Free Cash Flow (EV/FCFF)		 59.14 46.99 34.47 24.77 25.11 28.34 31.80 129.55 136.17 277.37 1,509.49
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.53 0.47 0.50 0.47 0.41 0.41 0.50 0.57 0.56 0.57 0.54
Long-Term Debt to Equity		 0.49 0.47 0.49 0.47 0.41 0.34 0.36 0.57 0.56 0.55 0.53
Financial Leverage		 0.27 0.26 0.27 0.22 0.18 0.17 0.20 0.24 0.19 0.21 0.22
Leverage Ratio		 1.97 1.95 1.99 1.91 1.85 1.80 1.89 1.93 1.87 1.86 1.89
Compound Leverage Factor		 1.90 1.89 1.83 1.89 1.84 1.80 1.87 1.89 1.81 1.76 1.83
Debt to Total Capital		 34.63% 32.10% 33.41% 31.88% 29.22% 29.14% 33.19% 36.50% 35.81% 36.29% 34.86%
Short-Term Debt to Total Capital		 2.77% 0.00% 0.66% 0.00% 0.00% 4.79% 9.00% 0.48% 0.17% 1.52% 0.60%
Long-Term Debt to Total Capital		 31.85% 32.10% 32.75% 31.88% 29.22% 24.36% 24.19% 36.01% 35.64% 34.77% 34.26%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 65.37% 67.90% 66.59% 68.12% 70.78% 70.86% 66.81% 63.50% 64.19% 63.71% 65.14%
Debt to EBITDA		 1.51 1.37 1.63 1.65 1.57 1.59 1.63 1.89 1.89 2.07 1.97
Net Debt to EBITDA		 0.78 0.69 0.74 0.59 0.39 0.44 0.54 1.05 0.97 1.11 1.01
Long-Term Debt to EBITDA		 1.39 1.37 1.60 1.65 1.57 1.33 1.19 1.86 1.88 1.99 1.94
Debt to NOPAT		 2.15 1.96 2.39 2.19 2.11 2.12 2.15 2.69 2.68 2.90 2.70
Net Debt to NOPAT		 1.11 0.98 1.09 0.78 0.52 0.59 0.71 1.50 1.37 1.56 1.38
Long-Term Debt to NOPAT		 1.98 1.96 2.35 2.19 2.11 1.77 1.57 2.65 2.67 2.78 2.65
Altman Z-Score		 6.08 5.85 5.19 4.81 5.94 6.27 5.84 4.73 5.39 3.99 4.36
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.11 2.37 2.29 2.61 2.68 2.15 1.78 2.09 2.20 2.09 2.25
Quick Ratio		 1.40 1.55 1.52 1.80 1.88 1.49 1.26 1.40 1.50 1.42 1.54
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -241 -216 16 461 649 530 232 -601 -599 -840 -911
Operating Cash Flow to CapEx		 389.47% 698.25% 693.83% 614.29% 538.89% 323.30% 491.30% 517.20% 444.33% 193.86% 351.46%
Free Cash Flow to Firm to Interest Expense		 -9.65 -9.01 0.66 20.97 29.48 26.50 10.54 -18.78 -21.40 -28.96 -32.52
Operating Cash Flow to Interest Expense		 11.84 16.58 23.42 23.45 22.05 16.65 20.55 15.03 15.39 7.62 12.93
Operating Cash Flow Less CapEx to Interest Expense		 8.80 14.21 20.04 19.64 17.95 11.50 16.36 12.13 11.93 3.69 9.25
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.65 0.66 0.66 0.64 0.62 0.61 0.60 0.58 0.57 0.58 0.58
Accounts Receivable Turnover		 5.20 5.34 5.21 5.07 4.89 4.97 5.06 4.98 4.98 5.07 5.20
Inventory Turnover		 3.17 3.13 3.30 3.26 3.11 3.09 2.89 2.97 2.96 3.11 3.23
Fixed Asset Turnover		 6.53 6.42 6.18 5.77 5.47 5.16 4.89 4.27 4.17 4.04 3.98
Accounts Payable Turnover		 6.21 6.51 6.80 6.75 6.48 6.92 6.24 6.21 5.81 6.32 6.27
Days Sales Outstanding (DSO)		 70.16 68.39 70.04 72.01 74.63 73.38 72.08 73.31 73.27 72.00 70.14
Days Inventory Outstanding (DIO)		 115.29 116.45 110.71 112.11 117.50 117.95 126.27 122.87 123.20 117.52 112.94
Days Payable Outstanding (DPO)		 58.81 56.06 53.71 54.08 56.34 52.72 58.45 58.77 62.82 57.72 58.23
Cash Conversion Cycle (CCC)		 126.64 128.78 127.04 130.04 135.79 138.60 139.89 137.41 133.66 131.79 124.86
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 7,142 7,153 6,828 6,826 6,825 6,922 6,870 7,784 7,750 8,010 8,111
Invested Capital Turnover		 1.01 1.02 1.03 1.00 0.96 0.94 0.95 0.89 0.90 0.89 0.91
Increase / (Decrease) in Invested Capital		 607 523 96 0.00 -317 -231 42 958 925 1,088 1,241
Enterprise Value (EV)		 45,927 40,920 36,858 30,967 38,440 40,656 42,080 39,259 44,905 32,487 34,354
Market Capitalization		 44,394 39,548 35,588 29,986 37,803 39,948 41,113 37,373 43,182 30,613 32,613
Book Value per Share		 $18.94 $19.55 $18.82 $19.98 $21.12 $21.20 $20.23 $20.53 $21.10 $21.52 $22.42
Tangible Book Value per Share		 $2.76 $3.39 $3.63 $4.82 $6.07 $6.26 $5.30 $3.04 $3.80 $4.09 $5.02
Total Capital		 8,580 8,514 8,347 8,580 8,743 8,770 8,835 9,288 9,390 9,631 9,779
Total Debt		 2,971 2,733 2,789 2,735 2,555 2,556 2,932 3,390 3,363 3,495 3,409
Total Long-Term Debt		 2,733 2,733 2,734 2,735 2,555 2,136 2,137 3,345 3,347 3,349 3,350
Net Debt		 1,533 1,372 1,270 981 637 708 967 1,886 1,723 1,874 1,741
Capital Expenditures (CapEx)		 76 57 81 84 90 103 92 93 97 114 103
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 1,130 1,108 996 993 973 994 883 780 787 856 885
Debt-free Net Working Capital (DFNWC)		 2,380 2,283 2,325 2,583 2,721 2,665 2,662 2,109 2,254 2,342 2,420
Net Working Capital (NWC)		 2,142 2,283 2,270 2,583 2,721 2,245 1,867 2,064 2,238 2,196 2,361
Net Nonoperating Expense (NNE)		 14 4.81 0.84 -14 -16 -9.06 -8.22 6.13 7.80 33 -5.51
Net Nonoperating Obligations (NNO)		 1,533 1,372 1,270 981 637 708 967 1,886 1,723 1,874 1,741
Total Depreciation and Amortization (D&A)		 67 71 71 62 62 63 63 69 72 73 72
Debt-free, Cash-free Net Working Capital to Revenue		 16.31% 15.74% 14.24% 14.53% 14.45% 15.08% 13.59% 11.98% 12.05% 12.91% 13.04%
Debt-free Net Working Capital to Revenue		 34.34% 32.43% 33.24% 37.80% 40.40% 40.43% 40.97% 32.40% 34.50% 35.33% 35.65%
Net Working Capital to Revenue		 30.91% 32.43% 32.46% 37.80% 40.40% 34.06% 28.74% 31.71% 34.26% 33.13% 34.78%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.19 $1.02 $0.38 $1.63 $1.19 $1.05 $0.97 $1.23 $1.12 $0.75 $1.18
Adjusted Weighted Average Basic Shares Outstanding		 296M 296M 294M 294M 293M 293M 290M 290M 285M 285M 284M
Adjusted Diluted Earnings per Share		 $1.19 $1.02 $0.38 $1.60 $1.18 $1.05 $0.97 $1.23 $1.11 $0.75 $1.18
Adjusted Weighted Average Diluted Shares Outstanding		 297M 297M 295M 296M 294M 293M 291M 291M 287M 285M 285M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 295.70M 295.38M 292.59M 293.00M 293.06M 291.76M 287.33M 285.60M 285.10M 284.06M 283.50M
Normalized Net Operating Profit after Tax (NOPAT)		 366 307 112 286 332 299 274 357 326 248 330
Normalized NOPAT Margin		 20.83% 17.87% 6.69% 16.92% 20.00% 19.00% 17.35% 21.00% 19.38% 14.87% 19.02%
Pre Tax Income Margin		 23.35% 21.96% 7.89% 24.88% 24.31% 23.78% 21.74% 23.57% 21.83% 15.59% 21.06%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 17.04 16.21 5.96 19.32 18.50 18.75 15.73 12.78 13.57 9.48 13.50
NOPAT to Interest Expense		 14.63 12.78 4.66 20.97 15.07 14.95 12.44 11.16 11.64 8.55 11.80
EBIT Less CapEx to Interest Expense		 14.00 13.83 2.58 15.50 14.41 13.60 11.55 9.88 10.11 5.55 9.82
NOPAT Less CapEx to Interest Expense		 11.59 10.41 1.29 17.16 10.98 9.80 8.26 8.25 8.17 4.62 8.12
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 19.20% 19.02% 23.04% 21.37% 21.60% 21.74% 19.25% 21.26% 21.92% 23.76% 22.95%
Augmented Payout Ratio		 77.17% 64.77% 78.64% 67.74% 62.06% 73.67% 82.59% 110.47% 120.41% 125.39% 79.10%

Key Financial Trends

Agilent Technologies has demonstrated solid financial performance over the last four years through Q3 2025, marked by steady revenue growth, strong profitability, and disciplined cash flow management.

Key Positive Highlights:
  • Revenue Growth: Operating revenue increased from approximately $1.72 billion in Q3 2022 to $1.74 billion in Q3 2025, showing consistent top-line growth over the period.
  • Improving Profitability: Net income rose significantly from $111 million in Q3 2023 to $336 million in Q3 2025, accompanied by improving earnings per share (from $0.38 to $1.18 diluted EPS).
  • Strong Operating Cash Flow: Net cash from operating activities grew from $326 million in Q3 2022 to $362 million in Q3 2025, reflecting robust operational efficiency.
  • Controlled Capital Spending: While capital expenditures have been steady (around $92M to $103M per quarter), Agilent has effectively balanced investment with free cash flow generation.
  • Healthy Balance Sheet: Total assets increased from $10.48 billion in Q3 2022 to $12.23 billion in Q3 2025, supported by rising cash & equivalents ($1.33B to $1.54B) and common equity growth ($5.56B to $6.37B).
  • Shareholder Returns: The company has consistently paid dividends with a slight increase in dividend per share from $0.225 in early 2023 to $0.248 in Q3 2025, along with ongoing share repurchases to return capital.
Neutral Aspects:
  • Stable Gross Margin: While gross profit and operating income have increased, operating expenses have also risen, resulting in relatively steady operating margins without significant expansion.
  • Moderate Debt Levels: Long-term debt remains around $3.35 billion across recent quarters, which is notable but manageable relative to the company’s equity base and cash generation.
  • Fluctuating Operating Working Capital: Changes in operating assets and liabilities have varied quarter-to-quarter, sometimes reducing operating cash flow.
Potential Concerns:
  • Significant Acquisitions Impact Cash Flow: Notably, Q4 2024 cash flow from investing activities included a large acquisition outflow of $859 million, which significantly impacted free cash flow for that period.
  • Increased Share Repurchases and Debt Repayments Impact Financing Cash Flow: Consistent high spend on share buybacks (e.g., $335M in Q3 2023, $85M in Q3 2025) and debt repayments weigh on net financing cash flow, potentially restricting liquidity flexibility.

Summary: Agilent Technologies has steadily grown revenue and earnings per share over the recent four-year period, supported by robust operating cash flow and a strong balance sheet. The company continues to invest prudently in capital expenditures and strategic acquisitions while maintaining shareholder returns through dividends and buybacks. However, cash flow impacts from large acquisitions and persistent high levels of repurchase and debt repayment warrant monitoring by investors. Overall, Agilent's financial trends reflect a well-managed growth company with solid fundamentals, making it attractive for retail investors focused on stable industrial technology exposure.

09/14/25 03:38 AM ETAI Generated. May Contain Errors.

Financials Breakdown Chart

Frequently Asked Questions About Agilent Technologies' Financials

When does Agilent Technologies' fiscal year end?

According to the most recent income statement we have on file, Agilent Technologies' financial year ends in October. Their financial year 2024 ended on October 31, 2024.

How has Agilent Technologies' net income changed over the last 10 years?

Agilent Technologies' net income appears to be on an upward trend, with a most recent value of $1.29 billion in 2024, rising from $549 million in 2014. The previous period was $1.24 billion in 2023. See Agilent Technologies' forecast for analyst expectations on what’s next for the company.

What is Agilent Technologies' operating income?
Agilent Technologies' total operating income in 2024 was $1.49 billion, based on the following breakdown:
  • Total Gross Profit: $3.54 billion
  • Total Operating Expenses: $2.05 billion
How has Agilent Technologies' revenue changed over the last 10 years?

Over the last 10 years, Agilent Technologies' total revenue changed from $4.05 billion in 2014 to $6.51 billion in 2024, a change of 60.8%.

How much debt does Agilent Technologies have?

Agilent Technologies' total liabilities were at $5.95 billion at the end of 2024, a 20.9% increase from 2023, and a 7.9% increase since 2014.

How much cash does Agilent Technologies have?

In the past 10 years, Agilent Technologies' cash and equivalents has ranged from $1.05 billion in 2022 to $2.68 billion in 2017, and is currently $1.33 billion as of their latest financial filing in 2024.

How has Agilent Technologies' book value per share changed over the last 10 years?

Over the last 10 years, Agilent Technologies' book value per share changed from 15.89 in 2014 to 20.53 in 2024, a change of 29.1%.


Related Companies

This page (NYSE:A) was last updated on 9/14/2025 by MarketBeat.com Staff
From Our Partners
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
IRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...
American Alternative | Sponsoredtc pixel
Apple’s falling behind
Apple just posted record-breaking results, yet its stock barely moved — because in today’s market, investors o...
Porter & Company | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Nvidia Times 1,000,000
Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...
Paradigm Press | Sponsoredtc pixel
Crypto Income (almost instantly)
How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...
Awesomely, LLC | Sponsoredtc pixel
Why Trump’s “Smart Dollar” could rewrite the rules
MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...
Stansberry Research | Sponsoredtc pixel